YOQNEAM, Israel and SAN RAMON, California, May 14 /PRNewswire/ --
- Company Hosts Non-Invasive Body Contouring Symposium and Featured in Hot Topics Panel
UltraShape Ltd., a global leader in non-invasive bodycontouring, will introduce the UltraShape(TM) CONTOUR I ver 2 at the upcoming2007 European Academy of Dermatology and Venearology (EADV) annual meeting.The upgraded system represents the latest in non-invasive body contouringtechnology based on focused ultrasound. It features new software and a newillumination system to improve power management and performance of thetracking and guidance system to optimize the UltraShape experience. Thelaunch comes just two months after UltraShape's CONTOUR I was named "Productof the Year" by the Ultrasonic Industry Association.
The company will host an educational symposium at EADVentitled "Emerging Practices in Non-Invasive Body Contouring," chaired by Dr.Ami Glicksman, plastic surgeon and co-founder of UltraShape. The symposiumwill feature recent experience with UltraShape's clinically-proven focusedultrasound solution for targeting and disrupting fat cells safely andeffectively. In addition, UltraShape will be highlighted in a EuropeanSociety for Cosmetic & Aesthetic Dermatology (ESCAD) Hot Topics panel held inconjunction with the EADV Congress.
"We are dedicated to providing a non-invasive treatmentplatform that safely delivers measurable circumference reduction and bodycontouring," said Rodger Stewart, President and Chief Executive Officer ofUltraShape. "These significant technology improvements to the CONTOUR Idemonstrate our commitment to further enhancing the UltraShape experience forclinicians and patients worldwide."
The UltraShape(TM) procedure is performed during a convenient, "walk-in,walk-out" session carried out in an office-based environment. The procedurerequires no anesthesia or sedation, with insignificant reported instances ofpatient discomfort. After treatment, patients immediately resume their dailyroutines and there is no need for maintenance treatments. The UltraShapeprocedure is available in 46 countries and over 30,000 treatments have beenperformed worldwide with high patient satisfaction.
Features of UltraShape CONTOUR I ver 2
The UltraShape CONTOUR I, based on patented focused ultrasoundtechnology, is the first clinically proven non-invasive body contouringsolution for both men and women. It is designed to target and disrupt fatcells, leaving surrounding structures such as skin, blood vessels, and nervesintact. Results from UltraShape's peer-reviewed published multi-centercontrolled clinical trial and independent clinical studies have demonstratedthe safe and effective clearance of lysed fat cells, and measurable fatthickness and circumference reduction. The UltraShape procedure is guided byproprietary real-time tracking and guidance software designed to deliversmooth, uniform body contouring results. The software guarantees adherence toa pre-determined treatment algorithm minimizing the risk of contourirregularities, a common side effect of liposuction, which is a highlytechnique-sensitive surgical procedure.
New features of the CONTOUR I ver 2 include new software providingimproved power management, enabling the clinician to control power levels foroptimal treatment. The software also has an optimized tracking and guidancesystem and 3-D treatment mapping based on advanced algorithms. Additionally,the new icon-based graphic user interface is more intuitive anduser-friendly, resulting in reduced treatment time. A new illumination systemincorporates the latest in LED based technology with an integrated camera,which provides more precise lighting to optimize performance of the trackingand guidance system. The LED lighting also provides softer lighting for anoverall enhanced patient experience.
The UltraShape CONTOUR I has CE Mark approval and was recently granted aHealthCanada license. It is not cleared by the FDA for marketing in theUnited States.
More About the EADV Symposium and Hot Topics
The 16th Congress of the EADV, taking place in Vienna, Austria, providesa platform for the presentation and discussion of the newest advances indermatology and venereology. UltraShape's symposium session includes a reviewof worldwide clinical experience with the UltraShape procedure and techniquesfor combining complementary technologies. The symposium will be held in SAT26, Hall N, at 17:30-18:45, Friday 18 May, and will feature lectures by Dr.Moshe Lapidoth (Israel), professor Jana Hercogova (Czech Republic), Dr. HyunJoo Kim (South Korea) and Dr. Luigi L Polla (Switzerland). Symposium detailsare available at http://www.ultrashape.com/eadv2007.aspx.
"We are proud to be the pioneer in non-invasive bodycontouring and lead the scientific training and discussion at this prominentscientific meeting which will further reinforce UltraShape as a global leaderin innovative non-invasive aesthetic procedures," said Glicksman.
Clinical experience with UltraShape will be also highlighted by leadingclinicians at the European Society for Cosmetic & Aesthetic Dermatology(ESCAD) at the 16th Congress of the EADV, in association with InternationalAcademy of Cosmetic Dermatology (IACD). Professor Hercogova and Dr. Pollawill participate in the Hot Topic discussion entitled "UltrasoundLiposuction" held on Wednesday 16 May, between 14:45- 15:15 in Hall C.
About UltraShape
UltraShape Ltd. is redefining aesthetic medicine by developing,manufacturing and marketing innovative non-invasive technologies for bodycontouring. The company is dedicated to providing clinically proven safe andeffective solutions that enhance the lives of patients worldwide. TheUltraShape proprietary non-invasive body contouring technology is based onfocused ultrasound that targets and selectively disrupts adipose (fat) cellswithout affecting surrounding structures. Founded in 2000, UltraShape is aprivately held and venture backed company with offices in the United States,Israel, France, United Kingdom, and Italy. For more information visitwww.ultrashape.com.
Notes to Media:
UltraShape will be supplying clinicians and journalists withinformation at Booth #95 during EADV. Information about system upgrades,latest clinical developments and general information will be available at thebooth. If you would like to arrange an interview with an UltraShapespokesperson, or a clinician currently using the system,please visit an UltraShape representative during the conference or callAbigail Marks (Mobile: +942-54-244-5807) to arrange a meeting time.
For more information please contact: Abigail Marks, UltraShape abigail@ultrashape.com +972-4-909-9260 Amanda McNulty Sheldon FischerHealth +1-310-577-7870 x 173 asheldon@fischerhealth.com Dariela Roffe, Porter Novelli dariela.roffe@porternovelli.co.uk +44-207-853-2234
UltraShape Inc
For more information please contact: Abigail Marks, UltraShape, abigail@ultrashape.com, +972-4-909-9260; Amanda McNulty Sheldon, FischerHealth, +1-310-577-7870 x 173, asheldon@fischerhealth.com; Dariela Roffe, Porter Novelli, dariela.roffe@porternovelli.co.uk, +44-207-853-2234
